9,016
Participants
Start Date
June 30, 2003
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
Irbesartan
oral administration (tablets) once daily
placebo
oral administration (tablets) once daily
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Buenos Aires
Sanofi-Aventis Administrative Office, Macquarie Park
Sanofi-Aventis Administrative Office, Vienna
Sanofi-Aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Santiago
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Hørsholm
Sanofi-Aventis Administrative Office, Helsinki
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Athens
Sanofi-Aventis Administrative Office, Causeway Bay
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, Kuala Lumpur
Sanofi-Aventis Administrative Office, México
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Lysaker
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Porto Salvo
Sanofi-Aventis Administrative Office, Singapore
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Bromma
Sanofi-Aventis Administrative Office, Geneva
Sanofi-Aventis Administrative Office, Taipei
Sanofi-Aventis Administrative Office, Guildford Surrey
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Sanofi
INDUSTRY